Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 1631 entries
View as:

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06659341 Org: User:
Start: 11/08/24 End: 11/05/27 Due: 11/05/28

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods

Phase: N/A Priority: Normal
NCT ID: NCT06904274 Org: User:
Start: 09/05/25 End: 01/20/27 Due: 01/20/28

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Phase: N/A Priority: Normal
NCT ID: NCT00839163 Org: User:
Start: 03/31/04 End: 10/31/05 Due: 10/31/06

Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00631969 Org: User:
Start: 04/30/08 End: 01/31/09 Due: 01/31/10

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02545049 Org: User:
Start: 09/17/15 End: 02/02/21 Due: 02/02/22

Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration

Phase: N/A Priority: Normal
NCT ID: NCT04236440 Org: User:
Start: 02/04/20 End: 06/24/21 Due: 06/24/22

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Phase: N/A Priority: Normal
NCT ID: NCT03773068 Org: User:
Start: 12/13/18 End: 08/12/19 Due: 08/12/20

18611 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02760563 Org: User:
Start: 10/19/15 End: 10/22/15 Due: 10/22/16

Avelox in Complicated Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00997997 Org: User:
Start: 10/31/05 End: 12/31/08 Due: 12/31/09

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01052298 Org: User:
Start: 04/30/09 End: 09/30/09 Due: 09/30/10

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

Phase: N/A Priority: Normal
NCT ID: NCT04297072 Org: User:
Start: 05/01/20 End: 02/28/21 Due: 02/28/22

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Phase: N/A Priority: Normal
NCT ID: NCT00439777 Org: User:
Start: 03/31/07 End: 12/31/11 Due: 12/31/12

A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability

Phase: N/A Priority: Normal
NCT ID: NCT02682654 Org: User:
Start: 02/05/16 End: 04/26/16 Due: 04/26/17

A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT03481946 Org: User:
Start: 05/10/18 End: 02/20/19 Due: 02/20/20

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

Phase: N/A Priority: Normal
NCT ID: NCT03182140 Org: User:
Start: 07/06/17 End: 03/31/20 Due: 03/31/21

Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01915576 Org: User:
Start: 09/30/13 End: 12/31/16 Due: 12/31/17

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03596762 Org: User:
Start: 11/20/18 End: 11/21/19 Due: 11/21/20

Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00310557 Org: User:
Start: 12/31/03 End: 12/31/04 Due: 12/31/05

Human Phototoxicity Test (823/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02962856 Org: User:
Start: 11/02/16 End: 11/05/16 Due: 11/05/17

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT03244462 Org: User:
Start: 08/18/17 End: 07/20/18 Due: 07/20/19

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01158183 Org: User:
Start: 07/31/07 End: 09/30/09 Due: 09/30/10

Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00919022 Org: User:
Start: 08/31/09 End: 08/31/11 Due: 08/31/12

Japanese BAY86-9766 Monotherapy Phase I Study

Phase: N/A Priority: Normal
NCT ID: NCT01179295 Org: User:
Start: 11/19/10 End: 04/27/12 Due: 04/27/13

A Study to Learn How Well a Monitoring System Called Continuous Glucose Monitoring (CGM) Which Measures Glucose on an Ongoing Basis Works and How Safe it is in Chinese Patients in Usual Practice

Phase: N/A Priority: Normal
NCT ID: NCT05038761 Org: User:
Start: 10/08/21 End: 03/21/22 Due: 03/21/23

Sun Protection Factor Assay (317/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02995018 Org: User:
Start: 01/03/17 End: 01/25/17 Due: 01/25/18